The Influence of Helicobacter pylori Infection on Hepatic Enzymes, Inflammatory Markers, and Hematological Parameters in Patients with Gastritis
Article Sidebar
Main Article Content
Abstract
Helicobacter pylori (HP) colonizes the gastric mucosa and causes gastric and extra-gastric disorders. Several liver diseases, such as Non-alcoholic fatty liver disease, seem to be caused by the gastrointestinal tract, which is primarily determined by the presence of bacteria like Helicobacter pylori. The study aims to evaluate the relationship between Helicobacter pylori infection and liver diseases by measuring liver enzymes, inflammatory markers, and hematological parameters among patients with gastritis and without Helicobacter pylori infection. A total of 1,325 patients who had gastritis diagnosed by gastroscopy were included in our study. They were divided into the HP– group (340 women, 323 men) and the HP+ group (330 women, 332 men). A control group (360 women, 260 men) without gastritis or HP infection was included in this study. HP was determined using the 13C urea breath test, which requires patients to swallow a capsule with water. Measurements of liver enzymes and complete blood cell counts were done in addition to interleukin-6(IL-6) and C-reactive protein (CRP). The results showed a significant increase in IL-6 and CRP in the HP+ group. Additionally, the mean levels of leukocytes and platelets were significantly increased in the HP+ group, but liver enzymes were within the normal range in both the HP+ & HP– groups. Although Helicobacter pylori causes elevation of indices of systemic inflammation, the liver did not show evidence of fatty infiltration, as liver enzymes were within normal limits.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Umar, Z.; Tang, J. W.; Marshall, B. J.; Tay, A. C. Y.; Wang, L. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings. Crit. Rev. Microbiol. 2025, 51(2), 369–398. https://doi.org/10.1080/1040841X.2024.2364194
Bansil, R.; Constantino, M. A.; Su-Arcaro, C.; Liao, W.; Shen, Z.; Fox, J. G. Motility of different gastric Helicobacter spp. Microorganisms 2023, 11(3), 634. https://doi.org/10.3390/microorganisms11030634
Li, J.; Yuan, W.; Liu, J.; Yang, B.; Xu, X.; Ren, X.; Jia, L. Association between Helicobacter pylori infection and type 2 diabetes mellitus: A retrospective cohort study and bioinformatics analysis. BMC Endocr. Disord. 2024, 24(1), 168. https://doi.org/10.1186/s12902-024-01694-2
Al-Yawer, M. A.; Alsiadi, W.; Hakman, A. A.; Ahmed, A. D. The influence of Helicobacter pylori infection on cardiovascular risk factors in patients with gastritis. SJFPS 2024, 3(1)
Alsiadi, W. A. W.; Al-Yawer, M. A.; Oudah, N. N.; Al-Shmgani, H. S. The influence of Helicobacter pylori infection on glycemic measures in patients with gastritis: A cohort study. Opera Med. Physiol. 2025, 12(1), 59–65. https://doi.org/10.24412/2500-2295-2025-1-58-65
Paik, J. M.; Henry, L.; De Avila, L.; Younossi, E.; Racila, A.; Younossi, Z. M. Mortality related to nonalcoholic fatty liver disease is increasing in the United States. Hepatol. Commun. 2019, 3(11), 1459–1471.
Kumar, A.; Kansal, D.; Gupta, S.; Sood, A.; Bodh, S. Raised liver enzyme in a patient receiving Helicobacter pylori triple regimen: A case report. IP Int. J. Compr. Adv. Pharmacol. 2022, 7(2), 106–107. https://doi.org/10.18231/j.ijcaap.2022.020
Polyzos, S. A.; Kountouras, J.; Papatheodorou, A.; Patsiaoura, K.; Katsiki, E.; Zafeiriadou, E.; Terpos, E. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013, 62(1), 121–126. https://doi.org/10.1016/j.metabol.2012.06.007
Kim, T. J.; Sinn, D. H.; Min, Y. W.; Son, H. J.; Kim, J. J.; Chang, Y.; et al. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. J. Gastroenterol. 2017, 52, 1201–1210. https://doi.org/10.1007/s00535-017-1337-y
Jamali, R.; Mofid, A.; Vahedi, H.; Farzaneh, R.; Dowlatshahi, S. The effect of Helicobacter pylori eradication on liver fat content in subjects with nonalcoholic fatty liver disease. Hepat. Mon. 2013, 13, e14679. https://doi.org/10.5812/hepatmon.14679
Okushin, K.; Takahashi, Y.; Yamamichi, N.; Shimamoto, T.; Enooku, K.; Fujinaga, H.; Koike, K. Helicobacter pylori infection is not associated with fatty liver disease. BMC Gastroenterol. 2015, 15, 1–10.
La Placa, G.; Covino, M.; Candelli, M.; Gasbarrini, A.; Franceschi, F.; Merra, G. Relationship between human microbiome and Helicobacter pylori. Microbiol. Res. 2025, 16, 24. https://doi.org/10.3390/microbiolres16010024
Baeg, M. K.; Yoon, S. K.; Ko, S. H.; Noh, Y. S.; Lee, I. S.; Choi, M. G. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J. Gastroenterol. 2016, 22(8), 2592. https://doi.org/10.3748/wjg.v22.i8.2592
Fan, N.; Peng, L.; Xia, Z.; Zhang, L.; Wang, Y.; Peng, Y. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. Front. Microbiol. 2018, 9, 73. https://doi.org/10.3389/fmicb.2018.00073
Pepys, M. B.; Hirschfield, G. M. C-reactive protein: A critical update. J. Clin. Invest. 2003, 111(12), 1805–1812. https://doi.org/10.1172/JCI18921
Pessar, D. A. E. H.; Galal, S. A.; Omira, M. M. A.; Al-Ghamdi, H. S.; Alghamdi, M. A.; Alghamdi, F. A.; et al. The role of Helicobacter pylori in psoriasis. Immunopathol. Persa 2025, 11(2), e43855. https://doi.org/10.34172/ipp.2025.43855
Al-Karawi, A. S.; Rasool, K. H.; Atoom, A. M.; Kadhim, A. S. Correlation between H. pylori infection and inflammatory markers. Al-Salam J. Med. Sci. 2023, 2(2), 20–24. https://doi.org/10.55145/ajbms.2023.1.2.004
Jiang, T.; Chen, X.; Xia, C.; Liu, H.; Yan, H.; Wang, G.; Wu, Z. Association between Helicobacter pylori infection and NAFLD. Sci. Rep. 2019, 9(1), 4874. https://doi.org/10.1038/s41598-019-41371-2
Wijarnpreecha, K.; Thongprayoon, C.; Panjawatanan, P.; Manatsathit, W.; Jaruvongvanich, V.; Ungprasert, P. Helicobacter pylori and NAFLD risk: A meta-analysis. J. Clin. Gastroenterol. 2018, 52(5), 386–391. https://doi.org/10.1097/MCG.0000000000000784
Kim, T. J.; Sinn, D. H.; Min, Y. W.; Son, H. J.; Kim, J. J.; Chang, Y.; et al. Helicobacter pylori and NAFLD. J. Gastroenterol. 2017, 52, 1201–1210. https://doi.org/10.1007/s00535-017-1337-y
Wang, J.; Dong, F.; Su, H.; Zhu, L.; Shao, S.; Wu, J.; Liu, H. H. pylori and NAFLD in females. Int. J. Med. Sci. 2021, 18(11), 2303–2311. https://doi.org/10.7150/ijms.50748
Franceschi, F.; Covino, M.; Roubaud Baudron, C. Helicobacter pylori and extragastric diseases. Helicobacter 2019, 24(1), e12636. https://doi.org/10.1111/hel.12636
Kountouras, J.; Papaefthymiou, A.; Polyzos, S. A.; Deretzi, G.; Vardaka, E.; Soteriades, E. S. Helicobacter pylori and hypertension. Microorganisms 2021, 9(11), 2351. https://doi.org/10.3390/microorganisms9112351
Karttunen, T. J.; Niemelä, S.; Kerola, T. Blood leukocyte differential in Helicobacter pylori infection. Dig. Dis. Sci. 1996, 41(7), 1332–1336. https://doi.org/10.1007/BF02088556
Wang, J.; Dong, F.; Su, H.; Zhu, L.; Shao, S.; Wu, J.; Liu, H. H. pylori and NAFLD in females. Int. J. Med. Sci. 2021, 18(11), 2303–2311. https://doi.org/10.7150/ijms.50748
Alsiadi, W. A. W.; Albayati, A. M.; Elhaboby, B. T. Detection of cytokines in renal failure patients. Indian J. Forensic Med. Toxicol. 2021, 15(2), 1470–1475. https://doi.org/10.37506/ijfmt.v15i2.14546
Han, Y. M.; Lee, J.; Choi, J. M.; Kwak, M. S.; Yang, J. I.; Chung, S. J.; Chung, G. E. Association between Helicobacter pylori and NAFLD. PLoS One 2021, 16(12), e0260994. https://doi.org/10.1371/journal.pone.0260994
Abd El-Maksoud, H. A.; Mohamed, G. E.; Alshaimaa, M. S.; Marwa, M. M. Biochemical relations of Helicobacter pylori infection. Benha Vet. Med. J. 2019, 36(1), 95–100. https://doi.org/10.21608/bvmj.2019.103401
Alsiadi, W. A. W.; Mahmood, M. M.; Hassan, A. S. Hematological denotations in renal failure. Indian J. Public Health Res. Dev. 2019, 10(6). https://doi.org/10.5958/0976-5506.2019.01391.3
Chang, W.; Cai, L.; Chen, T.; Ni, W.; Xie, Z.; Yang, C.; Liao, J. Helicobacter pylori infection and liver injury. Am. J. Trop. Med. Hyg. 2023, 108(4), 684–692. https://doi.org/10.4269/ajtmh.22-0340
Chen, X.; Peng, R.; Peng, D.; Xiao, J.; Liu, D.; Li, R. Relationship between H. pylori and NAFLD. Front. Cell. Infect. Microbiol. 2023, 13, 1282956. https://doi.org/10.3389/fcimb.2023.1282956
